Track topics on Twitter Track topics that are important to you
CareTaker Medical, Virginia Bio member, and an innovator in Continuous Non-Invasive Blood Pressure and wireless Vital Signs monitoring announced completion of a $3.4M investment round led by IrishAngels, KOFA Healthcare and Jaffray Woodriff (executed by his family office, Felton Group, LLC), with participation from both new and existing individual investors. Proceeds will accelerate the company's global commercialization activities for the FDA-Cleared, Wireless CareTaker® Continuous "Beat by Beat" Non-Invasive Blood Pressure ("CNIBP") and Vital Signs monitor which enables untethered, continuous patient monitoring with a simple finger cuff.
"We're grateful for the confidence of our investors and excited by the results of our initial sales efforts," said President and CEO Jeff Pompeo. "Feedback from our customers and distributors has been tremendous across all points of care, including surgery, critical care, infusion, anesthesia, remote monitoring, and even ambulatory monitoring. The ability to wirelessly stream continuous uninterrupted Blood Pressure and Vital Signs without invasive Arterial Catheters or bulky hoses is compelling for both clinicians and patients. CareTaker® provides clinicians with a comprehensive view of hemodynamic health data that typical intermittent 'spot check' arm cuffs can't provide, and patients enjoy freedom of mobility without compromising safety or efficacy."
"We were introduced to CareTaker Medical through a co-investor and were immediately impressed by Jeff and the management team, and their vast experience in the industry," said Kaitlyn Doyle, director at IrishAngels. "They have proven the technology, and are poised to be a leader in patient monitoring."
In addition to expanding its global sales and distribution channels, the company intends to forge more OEM partnerships to integrate their wireless CNIBP and Vital Signs technology with other patient monitoring platforms. In Q1 CareTaker Medical announced integration with the Philips IntelliVue family of patient monitors. The company is also testing additional hemodynamic parameters using their patented Pulse Decomposition Analysis technology and low-pressure, disposable Finger Cuff, which will be added to the CareTaker monitor next year.
Original Article: CareTaker Medical pulls in $3.4MNEXT ARTICLE
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...